Btk inhibition treats TLR7/IFN driven murine lupus. (scientific article published on 25 January 2016)

cites work (P2860)

Q39326265	An update on lupus animal models
Q58552065	BTK inhibition ameliorates kidney disease in spontaneous lupus nephritis
Q50066279	Bruton's Tyrosine Kinase, a Component of B Cell Signaling Pathways, Has Multiple Roles in the Pathogenesis of Lupus
Q54981834	Bruton's tyrosine kinase regulates TLR7/8-induced TNF transcription via nuclear factor-κB recruitment.
Q37730801	Btk-specific inhibition blocks pathogenic plasma cell signatures and myeloid cell-associated damage in IFNα-driven lupus nephritis.
Q90307978	Discovery of Affinity-Based Probes for Btk Occupancy Assays
Q64113828	Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models
Q47647317	Highly selective inhibition of Bruton's tyrosine kinase attenuates skin and brain disease in murine lupus
Q92734901	Immune Relevant and Immune Deficient Mice: Options and Opportunities in Translational Research
Q100737257	Kinase inhibition in autoimmunity and inflammation
Q38643755	Lupus nephritis and B-cell targeting therapy.
Q47961675	Pristane-induced lupus: considerations on this experimental model
Q39433250	Pyrrolo[2,3-d]pyrimidines active as Btk inhibitors
Q50068095	Recent developments in systemic lupus erythematosus pathogenesis and applications for therapy

P356	DOI	10.1016/J.CLIM.2016.01.012
P698	PubMed publication ID	26821304

P2093	author name string	Federica Morandi
		Daigen Xu
		Yin Wu
		Kai Fu
		Yi-Ying Chen
		Hui Tian
		Shinji L Okitsu
		Albertina Pereira
		Andrew T Bender
		Roland Grenningloh
		Eileen Samy
		Jared Head
		Lesley Liu-Bujalski
		Melinda Genest
		Richard Caldwell
		Ursula Koehler
P304	page(s)	65-77
P577	publication date	2016-01-25
P1433	published in	Clinical Immunology	Q15752921
P1476	title	Btk inhibition treats TLR7/IFN driven murine lupus.
P478	volume	164

Btk inhibition treats TLR7/IFN driven murine lupus.